Moreover, BSA-Apt enhanced PBMC-induced cytotoxicity against tumor cells in vitro (p < 0.05), presumably by mitigating PD-1/PD-L1-mediated immunosuppression (Figure 6). The gene discussed is CD274; the disease is neoplasm.